Next-generation dendritic cells for immunotherapy of acute myeloid leukemia

por Schnorfeil, Frauke, Lichtenegger, Felix, Geiger, Christiane, Köhnke, Thomas, Bücklein, Veit, Altmann, Torben, Wagner, Beate, Henschler, Reinhard, Bigalke, Iris, Kvalheim, Gunnar, Hiddemann, Wolfgang, Schendel, Dolores, Subklewe, Marion
Publicado 2014

Targeting CD157 in AML using a novel, Fc-engineered antibody construct

por Krupka, Christina, Lichtenegger, Felix S., Köhnke, Thomas, Bögeholz, Jan, Bücklein, Veit, Roiss, Michael, Altmann, Torben, Do, To Uyen, Dusek, Rachel, Wilson, Keith, Bisht, Arnima, Terrett, Jon, Aud, Dee, Pombo-Villar, Esteban, Rohlff, Christian, Hiddemann, Wolfgang, Subklewe, Marion
Publicado 2017

Toll‐like receptor 7/8‐matured RNA‐transduced dendritic cells as post‐remission therapy in acute myeloid leukaemia: results of a phase I trial

por Lichtenegger, Felix S, Schnorfeil, Frauke M, Rothe, Maurine, Deiser, Katrin, Altmann, Torben, Bücklein, Veit L, Köhnke, Thomas, Augsberger, Christian, Konstandin, Nikola P, Spiekermann, Karsten, Moosmann, Andreas, Boehm, Stephan, Boxberg, Melanie, Heemskerk, Mirjam HM, Goerlich, Dennis, Wittmann, Georg, Wagner, Beate, Hiddemann, Wolfgang, Schendel, Dolores J, Kvalheim, Gunnar, Bigalke, Iris, Subklewe, Marion
Publicado 2020